CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
REVENUES	$ 9,199	$ 4,364	$ 3,523
COST OF REVENUES	(8,398)	(730)	(630)
GROSS PROFIT	801	3,634	2,893
RESEARCH AND DEVELOPMENT EXPENSES	(30,412)	(24,889)	(27,352)
Less - grants	5,804	4,864	5,128
RESEARCH AND DEVELOPMENT EXPENSES, NET	(24,608)	(20,025)	(22,224)
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES	(9,356)	(7,279)	(9,228)
OPERATING LOSS	(33,163)	(23,670)	(28,559)
FINANCIAL EXPENSES	(10,665)	(3,735)	(4,935)
FINANCIAL INCOME	589	123	196
GAIN ON EXTINGUISHMENT OF CONVERTIBLE NOTES	14,063
FINANCIAL INCOME (EXPENSES) - NET	3,987	(3,612)	(4,739)
LOSS FROM CONTINUING OPERATIONS	(29,176)	(27,282)	(33,298)
(LOSS) INCOME FROM DISCONTINUED OPERATIONS	(189)	85,319	3,355
NET INCOME (LOSS) FOR THE YEAR	$ (29,365)	$ 58,037	$ (29,943)
Net Income (loss) per share of common stock - basic and diluted
Loss from continuing operations (in dollars per share)	$ (0.29)	$ (0.29)	$ (0.36)
Income from discontinued operations (in dollars per share)	(0.00)	0.90	0.04
Net (loss) income per share of common stock (in dollars per share)	$ (0.29)	$ 0.61	$ (0.32)
Weighted average number of shares of common stock used in computing loss per share of common stock, basic and diluted	101,387,704	94,922,390	92,891,846